These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7201506)

  • 1. Inhibition, by 2-oxo acids that accumulate in maple-syrup-urine disease, of lactate, pyruvate, and 3-hydroxybutyrate transport across the blood-brain barrier.
    Cremer JE; Teal HM; Cunningham VJ
    J Neurochem; 1982 Sep; 39(3):674-7. PubMed ID: 7201506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of 2-oxo acids on pyruvate utilization and fatty acid synthesis in rat brain.
    Clark JB; Land JM
    Biochem J; 1974 Apr; 140(1):25-9. PubMed ID: 4155948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier transport of the alpha-keto acid analogs of amino acids.
    Steele RD
    Fed Proc; 1986 Jun; 45(7):2060-4. PubMed ID: 3519290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
    Land JM; Mowbray J; Clark JB
    J Neurochem; 1976 Apr; 26(4):823-30. PubMed ID: 987160
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactate transport through the blood-retinal and the blood-brain barrier in rats.
    Alm A; Törnquist P
    Ophthalmic Res; 1985; 17(3):181-4. PubMed ID: 4011131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
    Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
    Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites.
    Gibson GE; Blass JP
    J Neurochem; 1976 Jun; 26(6):1073-8. PubMed ID: 945329
    [No Abstract]   [Full Text] [Related]  

  • 8. Transport of alpha-keto analogues of amino acids across blood-brain barrier in rats.
    Conn AR; Steele RD
    Am J Physiol; 1982 Oct; 243(4):E272-7. PubMed ID: 6751096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the inhibition by stilbene disulphonates and phloretin of lactate and pyruvate transport into rat and guinea-pig cardiac myocytes suggests the presence of two kinetically distinct carriers in heart cells.
    Wang X; Poole RC; Halestrap AP; Levi AJ
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):249-58. PubMed ID: 8439293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of pyruvate decarboxylation in rat brain by -ketoisocaproic acid.
    Bowden JA; McArthur CL; Fried M
    Biochem Med; 1971 Apr; 5(2):101-8. PubMed ID: 5167175
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial oxidation of leucine in skeletal muscle.
    Palmer TN; Gossain S; Sugden MC
    Biochem Mol Biol Int; 1993 Feb; 29(2):255-62. PubMed ID: 8495210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
    Lysiak W; Stepiński J; Angielski S
    Acta Biochim Pol; 1970; 17(2):131-41. PubMed ID: 5530500
    [No Abstract]   [Full Text] [Related]  

  • 13. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
    Lees GJ; Weiner N
    J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of alpha-keto acid transport across blood-brain barrier in rats.
    Conn AR; Fell DI; Steele RD
    Am J Physiol; 1983 Sep; 245(3):E253-60. PubMed ID: 6614164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the transport of pyruvate in liver mitochondria from normal and diabetic rats.
    Kielducka A; Paradies G; Papa S
    J Bioenerg Biomembr; 1981 Aug; 13(3-4):123-32. PubMed ID: 7309723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of pyruvate nad lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier.
    Halestrap AP
    Biochem J; 1976 May; 156(2):193-207. PubMed ID: 942406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of transport of lactate and pyruvate into rat hepatocytes. Evidence for the presence of a specific carrier similar to that in erythrocytes.
    Edlund GL; Halestrap AP
    Biochem J; 1988 Jan; 249(1):117-26. PubMed ID: 3342001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propylene glycol on redox state of the perfused rat liver--a note of caution.
    Schölmerich J; Kitamura S; Miyai K
    Res Exp Med (Berl); 1989; 189(1):39-42. PubMed ID: 2711035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.
    Patel MS
    Biochem J; 1974 Oct; 144(1):91-7. PubMed ID: 4462577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.